Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Beyond Meat to Sell

Argus Research Downgrades Beyond Meat to Sell

Argus Research analyst Kristina Ruggeri downgrades Beyond Meat (NASDAQ:BYND) from Hold to Sell.

byBenzinga Newsdesk

December 9, 2022

1 minute read

Argus Research analyst Kristina Ruggeri downgrades Beyond Meat (NASDAQ:BYND) from Hold to Sell.

B of A Securities Downgrades Pioneer Natural Resources to Underperform, Lowers Price Target to $244

By Benzinga Newsdesk

July 19, 6:52 AM

B of A Securities analyst Doug Leggate downgrades Pioneer Natural Resources (NYSE:PXD) from Neutral to Underperform and lowers the price target from $272 to $244.

PXD

Analyst Ratings

Expert Ratings for Rocket Pharmaceuticals

By Benzinga Insights

May 23, 1:02 PM

Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

RCKT

Verve Therapeutics Amends Gene Editing Pact With Beam Therapeutics

By Vandana Singh

July 7, 8:28 AM

Verve Therapeutics Inc (NASDAQ:VERV) entered into an Amended and Restated Collaboration and License Agreement with Beam Therapeutics Inc (NASDAQ:BEAM), which amended…

BEAM